RxDoctor Payments Data

Nicola Lowrey

Medical · Orange, CANPI 1760419428

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $474,450 of the $654,576 with a category attached, or 72.5%. AbbVie accounts for 99.8% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2021 at $211,218 and has fallen 61.9% since, to $80,491 in 2025. Among medical clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$654,576in general payments, 2019–2025

Across 1,159 payments — averaging $564.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$654K
  • Merz North America, Inc.$645
  • Galderma Laboratories, L.p.$370

What the payments were for

  • Consulting fees$87,53413%
  • Speaking & faculty fees$474,45072%
  • Travel & lodging$71,45911%
  • Food & beverage$21,0083%
  • Education$1250%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)1,144$653,561
Merz North America, Inc.6$645
Galderma Laboratories, L.p.9$370

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$654,576 in reported general payments places this provider in the 95th percentile of 2,087 medical providers in California.

See all medical providers in California

Other medical in Orange

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →